Search by Journal

  • HOME 
  •  >  Search by Journal
  •  >  Journal of Japanese Medical Society for Lung Surfactant and Biological Interface

Journal of Japanese Medical Society for Lung Surfactant and Biological Interface

Volume 56, Issue / 2025
English Article   Japanese Article
  • Please note that metadata of J-type articlesare generated by machine-translation and the original texts are written in Japanese.
Japanese Article Greetings of the director appointment
千葉弘文
Journal of Japanese Medical Society for Lung Surfactant and Biological Interface 56: 2025.
Japanese Article A proposed treatment algorithm for moderate to severe autoimmune pulmonary alveolar proteinosis based on a specific clinical study of salgramostim inhalation therapy. - Focusing on the PAGE II clinical trial -
中田光1), 半田知宏2), 坂上拓郎3), 鈴木拓児4), 谷野功典5), 赤坂圭一6), 富井啓介7), 坂本憲穂8), 江田良輔9), 北村信隆10)
Journal of Japanese Medical Society for Lung Surfactant and Biological Interface 56: 1-4, 2025.
Japanese Article What is the serum KL-6 level as a risk factor for lung cancer? : From a cohort study of indium handling workers.
中野真規子
Journal of Japanese Medical Society for Lung Surfactant and Biological Interface 56: 5-6, 2025.
Japanese Article Development of the new therapeutic drug candidate using Maillard reaction
宮崎泰成, 園田史朗, 小松崎恵子
Journal of Japanese Medical Society for Lung Surfactant and Biological Interface 56: 7-15, 2025.
Japanese Article 1. GM-CSF inhalation therapy for the pediatric intractable case of the autoimmune alveolar proteinosis
田中博之1), 深見正弥1), 天野瞳1), 松原彩子1), 片野拓馬1), 米澤利幸1), 太田航貴2), 村瀬博希2), 山口悦郎1), 伊藤理1)
Journal of Japanese Medical Society for Lung Surfactant and Biological Interface 56: 16-20, 2025.
Japanese Article 2. GM-CSF inhalation therapy for the case recurrent after the transplant
石本裕士1), 坂本憲穂1), 中田光2), 迎寛1)
Journal of Japanese Medical Society for Lung Surfactant and Biological Interface 56: 21-22, 2025.
Japanese Article 3. Long-term prognosis observation study after GM-CSF inhalation therapy in autoimmune pulmonary alveolar proteinosis (Real PAP History : RPH study)
吉田知栄子
Journal of Japanese Medical Society for Lung Surfactant and Biological Interface 56: 23-24, 2025.
Japanese Article 4. How to build treatment strategies for the obstinateness case
石田学
Journal of Japanese Medical Society for Lung Surfactant and Biological Interface 56: 25-27, 2025.
Japanese Article 5. Usefulness of the biomarker measurement in the interstitial lung disease practice
千葉弘文
Journal of Japanese Medical Society for Lung Surfactant and Biological Interface 56: 28-31, 2025.
Japanese Article 1. Depressant action of the Seihaito for the differentiation of the respiratory epithelia beaker cells which we induced by IL-13
礒濱洋一郎1,2), 石橋紀香1), 村上一仁1), 菅谷柊2)
Journal of Japanese Medical Society for Lung Surfactant and Biological Interface 56: 32-32, 2025.
Japanese Article 2. Examination of the IL-6 amplifier inhibition mechanism by humoral factor Stanniocalcin-1 (STC-1) derived from a mesenchyma system stem cell
大河内眞也1), 兼平雅彦2), 色川俊也1), 小川浩正1), 岡田克典3), 黒澤一1)
Journal of Japanese Medical Society for Lung Surfactant and Biological Interface 56: 33-35, 2025.
Japanese Article 3. The involvement of osteoclast-like cells in asbestos-induced pulmonary fibrosis
田中悠祐1,2), 高橋有毅2,3), 千葉弘文1), Frank McCormack2)
Journal of Japanese Medical Society for Lung Surfactant and Biological Interface 56: 36-36, 2025.
Japanese Article 4. Maintenance of remission after GM-CSF inhalation therapy for autoimmune pulmonary alveolar proteinosis.
田澤立之1), 大河内眞也2), 中田光3)
Journal of Japanese Medical Society for Lung Surfactant and Biological Interface 56: 37-38, 2025.
Japanese Article 5. The mucous membrane Adjuvant SF-10 mixture new model corona vaccine transrespiratory tract administration derived from human pulmonary surfactant induced long-term immunity
木本貴士1,2), 堺聡子2), 亀田桂子2), 高橋悦久2), 澤淵貴子2), 木戸博2)
Journal of Japanese Medical Society for Lung Surfactant and Biological Interface 56: 39-40, 2025.
▲